Clinical Trial Update: An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423

View source ↗

Summary

A completed clinical trial analyzing urinary proteases as potential biomarkers for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Hepatocellular Carcinoma, Liver Disease | Status: COMPLETED